September 2025 in “Asian Journal of Neurosurgery” Minimizing hair shaving before brain tumor surgery can improve self-esteem.
Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.
July 2025 in “SKIN The Journal of Cutaneous Medicine” Ritlecitinib is generally safe for alopecia areata patients over 72 months.
Resident doctors had more facial skin discoloration than medical students during COVID-19.
January 2025 in “Acta Dermatovenerologica Alpina Pannonica et Adriatica” Iron deficiency is linked to hair loss in adolescents, especially females, in northern Sudan.
December 2024 in “Clinical Cosmetic and Investigational Dermatology” Alopecia areata might help slow down certain cancers.
September 2024 in “African Journal of Biomedical Research” Alopecia areata patients have lower vitamin D and slightly lower copper levels, so these should be checked.
July 2024 in “Deleted Journal” The Ayurvedic program effectively manages hair loss due to iron deficiency anemia.
April 2024 in “ScienceRise. Pharmaceutical science” Men with hair loss feel it affects their emotions and life quality, and want more effective treatments.
April 2024 in “Dermatology and therapy” In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.
January 2024 in “Hypertension research” More research is needed to understand sex and racial differences in long COVID.
December 2023 in “Frontiers in oncology” Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.
December 2023 in “Y Dược học” Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.
November 2023 in “Curēus” Higher stress levels are linked to more skin problems, especially in young women.
Women with PCOS, especially with hirsutism, should be screened for depression and anxiety.
January 2023 in “Research Square (Research Square)” Blacks and Hispanics have higher chances of alopecia areata than Whites.
January 2023 in “MEDS Clinical Medicine” Urinary stone cases in Wuwei City increased significantly from 1995 to 2016.
December 2022 in “The Indian journal of chest diseases & allied sciences” Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.
September 2022 in “Research Square (Research Square)” Probiotics and synbiotics may help with PCOS symptoms, but more research is needed.
June 2022 in “Research Square (Research Square)” Urinary stones increased in Wuwei, China, especially in males, suggesting the need for better screening and healthcare.
Sex hormones likely did not affect COVID-19 outcomes in South Korea.
Premature greying of hair affects the social lives of medical students but not their self-esteem.
January 2019 in “Actas urológicas españolas” Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.
December 2018 in “Neuroradiology” MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.
February 2017 in “Cancer Causes & Control” Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.
December 2010 in “Jurnal Natural (Faculty of Mathematics and Natural Science, Syiah Kuala University)” Age, race, family history, and certain genetic factors increase prostate cancer risk.
November 2010 in “Clin-Alert” Monitoring for adverse effects in clinical treatments is crucial.
January 2010 in “Springer eBooks” Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.
Hair properties change under electromagnetic fields and are influenced by individual characteristics and the environment.
June 2006 in “American Journal of Epidemiology” Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.